Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01677273
Other study ID # B299
Secondary ID
Status Completed
Phase N/A
First received August 29, 2012
Last updated July 26, 2013
Start date September 2012
Est. completion date July 2013

Study information

Verified date July 2013
Source University of Copenhagen
Contact n/a
Is FDA regulated No
Health authority Denmark: Ethics Committee
Study type Interventional

Clinical Trial Summary

The primary aim is to examine and compare the effects of hydrolyzed casein (HC), intact casein (IC) and intact whey protein (IWP) on diet-induced thermogenesis (DIT). Furthermore, to study the effects on appetite regulation assessed by subjective appetite sensations, ad libitum energy intake and appetite regulating hormones.

Whey and casein differ in absorption and digestion rate, with whey being a fast protein and casein being a slow protein. When casein undergoes hydrolysis the absorption and digestion rates approaches the rates of whey. In the present study the importance of absorption rate and amino acid composition, in regards to energy expenditure and appetite regulation, will be examined. HC and IC have identical amino acid composition, but differ in absorption rate, whereas HC and IWP have similar absorption rates, but differ in amino acid composition. We hypothesize that consumption of HC will increase DIT and fat oxidation to a greater extend that IC. Moreover, that HC and IWP will increase satiety shortly after protein consumption, whereas IC will be more satiating after several hours.

The study is a controlled, randomized, 3-arm crossover study. It consists of three visits in a respiratory chamber separated by at least two weeks. 26 healthy, overweight and obese (BMI 27-35 kg/m2) young men will be enrolled and randomized to the order of the three protein supplements (HC, IC or IWP). At each visit protein supplements (containing either HC, IC or IWP) will be served as breakfast, lunch and dinner. Respiratory measures will be obtained over 24 hours and appetite will be assessed by visual analogue scales and appetite regulating hormones. Furthermore, ad libitum energy intake will be assessed.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date July 2013
Est. primary completion date July 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Healthy young men and woman

- Overweight and obese (BMI 27-35 kg/m2)

- 18-40 years

- Women must have a regular menstrual cycle

Exclusion Criteria:

- Allergic to dairy products or other food components

- Vegetarians

- Weight change >3kg within 2 months prior to start of the study

- Use of alcohol >14 drinks/wk

- Drug abuse

- Smoking

- Physically active >10 hrs/wk

- Use of over-the-counter or prescription medication that influences body weight, appetite or metabolism

- Diabetes Mellitus

- Dyslipidemia

- Diseases, which influence metabolism

- Donation of blood 3 months prior to start of the study

- Subjects with a hemoglobin value < 8 mol/L (measured at screening)

- Subjects with a blood glucose level > 6.1 mmol/l (110 mg/dl) (measured at screening)

- Subjects who are unable to give an informed consent.

- Pregnant and lactating women

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Hydrolyzed casein
30 g protein/supplement, 4 supplements/visit
Intact casein
30 g protein/supplement, 4 supplements/visit
Intact whey protein
30 g protein/supplement, 4 supplements/visit

Locations

Country Name City State
Denmark Department of Human Nutrion Frederiksberg

Sponsors (5)

Lead Sponsor Collaborator
University of Copenhagen Arla Foods, FrieslandCampina, The Danish Dairy Research Foundation, Denmark, The Ministry of Science, Technology and Innovation, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diet-induced thermogenesis 24 hours No
Secondary Appetite assessed by visual analogue scales 24 hours No
Secondary Appetite assessed by ad libitum energy intake 1 single meal No
Secondary Appetite regulating hormones in plasma 4 hours No
Secondary Components of respiratory measures (basal metabolic rate, sleeping metabolic rate and substrate oxidations) 24 hours No
Secondary Differences in insulin, glucose and atrial natriuretic peptide 4 hours No
Secondary Ad libitum energy intake assessed by 24 hour dietary records 24 hours No
Secondary NMR-spectroscopy based metabonomics profiling of urin 24 hours No